Business Context and Reporting Period
Company: MDXHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: November 2023
Date of Filing: November 6, 2023
This filing serves to furnish a press release issued by the Company on November 6, 2023. The registrant is a Belgian entity headquartered in Herstal, Belgium, and files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet referencing an attached press release (Exhibit 99.1) rather than a financial statement itself.
Material Changes
No material financial changes or comparative period data are disclosed within the text of this Form 6-K. The filing indicates the dissemination of information contained in the attached press release but does not summarize the content of that release.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a standard legal disclaimer stating that the information in the attached press release is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section nor incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in the body of this filing.
Key Facts for Investor Verification
- Source of Information: Investors must review the attached Exhibit 99.1 (Press Release dated November 6, 2023) to obtain the actual substance of the announcement, as the Form 6-K text contains no operational or financial details.
- Legal Status: The press release is furnished, not filed, meaning it does not carry the same legal liability protections or incorporation by reference as a standard SEC filing.
- Signatory: The report was signed by Michael McGarrity, Chief Executive Officer.